Amphastar Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Amphastar Pharmaceuticals,

09/11/2021 03:21

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 46 cents​​ per share for the quarter ended
in September. The mean expectation of six analysts for the
quarter was for earnings of 24 cents per share.
* Revenue rose 34.5% to $112.20 million from a year ago; 
analysts expected $103.24 million. 
* Amphastar Pharmaceuticals Inc's reported EPS for the quarter
was 59 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.7% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Amphastar Pharmaceuticals Inc shares had risen by 5.6% this
quarter and lost 0.1% so far this year.
* The company reported quarterly net income of $29.55 million.
* Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $23.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 03:20 a.m.
 ​All figures in US dollars unless otherwise stated